7 results
Summary of dosing recommendations in renal impairment of commonly used hypoglycaemic agents

#Diabetes #Diabetic #Medications #Pharmacology #Dosing
hypoglycaemic agents #Diabetes ... #Diabetic #Medications ... #Pharmacology # ... Renal #Impairment #CKD ... #Table #GFR #Hypoglycemics
Adjusted Pain Medication Dosing based on GFR

#Renal #Dosing #Pain #Pharmacology #Opiates #CKD #Gabapentin #Table
based on GFR ... #Renal #Dosing # ... Pain #Pharmacology ... #Opiates #CKD # ... Gabapentin #Table
Estimating the Total Daily Dose (TDD) of Insulin: Weight-Based Dosing
TDD in units of insulin = N
Insulin: Weight-Based ... Dosing TDD in ... (stage IV or V CKD ... #pharmacology # ... endocrinology #diabetes
Phosphate binders - quick reference chart of maximum daily dose. Most patients with CKD will require
patients with CKD ... since they are not able ... Purposes Only* #CKD ... Hyperphosphatemia #Dose #Dosing ... #Pharmacology #
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Diabetes Mellitus ... appropriately • Weight-based ... #Medications #pharmacology ... #comparison #table ... #endocrinology
Veltassa (Patiromer) 
MECHANISM: Potassium Binder 
INDICATION: Treatment of Hyperkalemia 
FORMULATION: Powder for oral suspension 
DOSING: 8.4
oral suspension DOSING ... 25.2 g if needed, based ... patients with CKD ... , HF, or diabetes ... #Hyperkalemia #Pharmacology
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist
Dosing:
3 mg daily x 30 days, then 7 mg
GLP-1 Agonist Dosing ... drug to remain stable ... #semaglutide #Diabetes ... #Pharmacology # ... Endocrinology